BNTX logo

BioNTech SE (BNTX) Operating profit

annual operating profit:

-$644.76M-$1.62B(-165.87%)
December 31, 2024

Summary

  • As of today (May 29, 2025), BNTX annual operating income is -$644.76 million, with the most recent change of -$1.62 billion (-165.87%) on December 31, 2024.
  • During the last 3 years, BNTX annual operating profit has fallen by -$18.31 billion (-103.65%).
  • BNTX annual operating profit is now -103.65% below its all-time high of $17.66 billion, reached on December 31, 2021.

Performance

BNTX Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXincome statement metrics

quarterly operating profit:

-$562.00M-$1.49B(-160.80%)
March 1, 2025

Summary

  • As of today (May 29, 2025), BNTX quarterly operating income is -$562.00 million, with the most recent change of -$1.49 billion (-160.80%) on March 1, 2025.
  • Over the past year, BNTX quarterly operating profit has dropped by -$11.08 million (-2.01%).
  • BNTX quarterly operating profit is now -110.46% below its all-time high of $5.37 billion, reached on September 30, 2021.

Performance

BNTX quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXincome statement metrics

TTM operating profit:

-$666.41M-$11.08M(-1.69%)
March 1, 2025

Summary

  • As of today (May 29, 2025), BNTX TTM operating income is -$666.41 million, with the most recent change of -$11.08 million (-1.69%) on March 1, 2025.
  • Over the past year, BNTX TTM operating profit has dropped by -$377.75 million (-130.87%).
  • BNTX TTM operating profit is now -103.18% below its all-time high of $20.97 billion, reached on March 31, 2022.

Performance

BNTX TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

BNTX Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-165.9%-2.0%-130.9%
3 y3 years-103.7%-110.5%-103.2%
5 y5 years-217.3%-758.8%-204.6%

BNTX Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-103.7%at low-110.5%+46.0%-103.2%+14.9%
5 y5-year-103.7%at low-110.5%+46.0%-103.2%+14.9%
alltimeall time-103.7%at low-110.5%+46.0%-103.2%+14.9%

BNTX Operating profit History

DateAnnualQuarterlyTTM
Mar 2025
-
-$562.00M(-160.8%)
-$666.41M(+1.7%)
Dec 2024
-$644.76M(-165.9%)
$924.39M(+7904.8%)
-$655.33M(-16.3%)
Sep 2024
-
$11.55M(-101.1%)
-$782.81M(+9.5%)
Jun 2024
-
-$1.04B(+88.8%)
-$714.77M(+147.6%)
Mar 2024
-
-$550.92M(-169.1%)
-$288.66M(-129.9%)
Dec 2023
$978.90M(-92.5%)
$796.91M(+901.3%)
$965.11M(-74.0%)
Sep 2023
-
$79.59M(-113.0%)
$3.71B(-36.8%)
Jun 2023
-
-$614.24M(-187.4%)
$5.87B(-31.2%)
Mar 2023
-
$702.85M(-80.1%)
$8.53B(-35.2%)
Dec 2022
$12.98B(-26.5%)
$3.54B(+58.2%)
$13.16B(-11.5%)
Sep 2022
-
$2.24B(+9.3%)
$14.86B(-17.4%)
Jun 2022
-
$2.05B(-61.6%)
$18.00B(-14.2%)
Mar 2022
-
$5.33B(+1.7%)
$20.97B(+19.2%)
Dec 2021
$17.66B
$5.24B(-2.5%)
$17.59B(+39.2%)
DateAnnualQuarterlyTTM
Sep 2021
-
$5.37B(+7.1%)
$12.64B(+79.4%)
Jun 2021
-
$5.02B(+156.8%)
$7.05B(+263.5%)
Mar 2021
-
$1.95B(+571.1%)
$1.94B(-2482.3%)
Dec 2020
-$94.10M(-53.7%)
$291.16M(-233.6%)
-$81.35M(-81.1%)
Sep 2020
-
-$217.98M(+144.7%)
-$431.12M(+69.6%)
Jun 2020
-
-$89.10M(+36.2%)
-$254.14M(+16.1%)
Mar 2020
-
-$65.44M(+11.7%)
-$218.82M(+7.7%)
Dec 2019
-$203.19M(+219.2%)
-$58.61M(+42.9%)
-$203.17M(+37.9%)
Sep 2019
-
-$41.00M(-23.8%)
-$147.36M(+12.1%)
Jun 2019
-
-$53.77M(+8.0%)
-$131.51M(+69.2%)
Mar 2019
-
-$49.79M(+1683.5%)
-$77.74M(+178.2%)
Dec 2018
-$63.65M(-8.3%)
-$2.79M(-88.9%)
-$27.94M(+11.1%)
Sep 2018
-
-$25.15M
-$25.15M
Dec 2017
-$69.40M
-
-

FAQ

  • What is BioNTech SE annual operating income?
  • What is the all time high annual operating profit for BioNTech SE?
  • What is BioNTech SE annual operating profit year-on-year change?
  • What is BioNTech SE quarterly operating income?
  • What is the all time high quarterly operating profit for BioNTech SE?
  • What is BioNTech SE quarterly operating profit year-on-year change?
  • What is BioNTech SE TTM operating income?
  • What is the all time high TTM operating profit for BioNTech SE?
  • What is BioNTech SE TTM operating profit year-on-year change?

What is BioNTech SE annual operating income?

The current annual operating profit of BNTX is -$644.76M

What is the all time high annual operating profit for BioNTech SE?

BioNTech SE all-time high annual operating income is $17.66B

What is BioNTech SE annual operating profit year-on-year change?

Over the past year, BNTX annual operating income has changed by -$1.62B (-165.87%)

What is BioNTech SE quarterly operating income?

The current quarterly operating profit of BNTX is -$562.00M

What is the all time high quarterly operating profit for BioNTech SE?

BioNTech SE all-time high quarterly operating income is $5.37B

What is BioNTech SE quarterly operating profit year-on-year change?

Over the past year, BNTX quarterly operating income has changed by -$11.08M (-2.01%)

What is BioNTech SE TTM operating income?

The current TTM operating profit of BNTX is -$666.41M

What is the all time high TTM operating profit for BioNTech SE?

BioNTech SE all-time high TTM operating income is $20.97B

What is BioNTech SE TTM operating profit year-on-year change?

Over the past year, BNTX TTM operating income has changed by -$377.75M (-130.87%)
On this page